Cookie Consent by PrivacyPolicies.com

May 6, 2021

Dr. Simón INCLIVA research group and the HUTER consortia attends to the HUMAN CELL ATLAS Virtual Meeting.

Event: HCA General Meeting

Date: 2021 June 28th - 30th

The goals of the 2021 HCA General Meeting are to convene the HCA community virtually and to share updates and insights on new HCA research and initiatives, as well as to highlight the work of the HCA Biological Networks and continue to build on the progress from the HCA Biological Network Seminar Series.


The HCA plans to have a virtual poster room, with two interactive poster viewing sessions: One session in a time zone convenient to Asia/Australia and the other in a time zone convenient to Africa/Americas/Europe. Interested poster presenters will need to submit abstracts via the registration site. Abstracts due Friday, May 14, 5 p.m. EDT, notifications will go out the week of June 1.


HUTER is represented in the Reproduction Biological Network through the network coordinators Dr. Cecilia Lindskog and Dr. Roser Vento-Tormo.

About the Human Uterus Cells Atlas – HUTER

The human uterus is a flagship reproductive organ with profound implications not only in reproduction but also in women ́s health. HUTER can advance the Human Cell Atlas initiative for the exploitation potential in Obstetrics and Gynecology and biomedicine research areas such as Regenerative Medicine or Reproductive Medicine.

The uterus is itself a model for regenerative medicine since (i) endometrial tissue regenerates monthly and its transformation is executed through dynamic changes in states and interactions of multiple cell types, and (ii) myometrial tissue has remarkable regenerative capacity and extensive remodelling throughout pregnancy. Hence, the primary motivation HUTER proposal stems from the need to better understand the human uterus in order to more effectively address uterine diseases that impact women ́s health such as myomas or endometriosis and/or might contribute to infertility, infant and maternal mortality and morbidity.

HUTER technological and biological platform will be a crucial resource for the scientific and clinical communities to define the cellular basis of health and disease, allowing the rapid development of new diagnosis and prognosis tools and therapeutic advancements in the field.

Link to the project website: https://huter-hca.eu/